<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1216" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1216/" /><meta name="ncbi_pagename" content="Deafness-Dystonia-Optic Neuronopathy Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Deafness-Dystonia-Optic Neuronopathy Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Deafness-Dystonia-Optic Neuronopathy Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/11/21" /><meta name="citation_author" content="Lisbeth Tranebjærg" /><meta name="citation_pmid" content="20301395" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1216/" /><meta name="citation_keywords" content="DDON" /><meta name="citation_keywords" content="Mohr-Tranebjaerg Syndrome" /><meta name="citation_keywords" content="Mohr-Tranebjaerg Syndrome" /><meta name="citation_keywords" content="Mitochondrial import inner membrane translocase subunit Tim8 A" /><meta name="citation_keywords" content="TIMM8A" /><meta name="citation_keywords" content="Deafness-Dystonia-Optic Neuronopathy Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Deafness-Dystonia-Optic Neuronopathy Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Lisbeth Tranebjærg" /><meta name="DC.Date" content="2019/11/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1216/" /><meta name="description" content="Males with deafness-dystonia-optic neuronopathy (DDON) syndrome have prelingual or postlingual sensorineural hearing impairment in early childhood, slowly progressive dystonia or ataxia in the teens, slowly progressive decreased visual acuity from optic atrophy beginning at approximately age 20 years, and dementia beginning at approximately age 40 years. Psychiatric symptoms such as personality change and paranoia may appear in childhood and progress. The hearing impairment appears to be consistent in age of onset and progression, whereas the neurologic, visual, and neuropsychiatric signs vary in degree of severity and rate of progression. Females may have mild hearing impairment and focal dystonia." /><meta name="og:title" content="Deafness-Dystonia-Optic Neuronopathy Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Males with deafness-dystonia-optic neuronopathy (DDON) syndrome have prelingual or postlingual sensorineural hearing impairment in early childhood, slowly progressive dystonia or ataxia in the teens, slowly progressive decreased visual acuity from optic atrophy beginning at approximately age 20 years, and dementia beginning at approximately age 40 years. Psychiatric symptoms such as personality change and paranoia may appear in childhood and progress. The hearing impairment appears to be consistent in age of onset and progression, whereas the neurologic, visual, and neuropsychiatric signs vary in degree of severity and rate of progression. Females may have mild hearing impairment and focal dystonia." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1216/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ddon/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1216/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88F351E040D7810000000005190206.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1216_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1216_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/dfn-myop/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/dent/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1216_"><span class="title" itemprop="name">Deafness-Dystonia-Optic Neuronopathy Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: DDON, Mohr-Tranebjaerg Syndrome</div><p class="contrib-group"><span itemprop="author">Lisbeth Tranebj&#x000e6;rg</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1216_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1216_ai__"><div class="contrib half_rhythm"><span itemprop="author">Lisbeth Tranebj&#x000e6;rg</span>, MD, PhD<div class="affiliation small">Professor of Medical Genetics and Genetic Audiology<br />Department of Clinical Genetics<br />University Hospital/The Kennedy Center<br />Institute of Clinical Medicine;<br />The Panum Institute<br />University of Copenhagen<br />Copenhagen, Denmark<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="kd.uk.dnus@greajbenart" class="oemail">kd.uk.dnus@greajbenart</a><span style="unicode-bidi: bidi-override; direction: ltr;">; </span><a href="mailto:dev@null" data-email="kd.hnoiger@greajbenart.htebsil" class="oemail">kd.hnoiger@greajbenart.htebsil</a><div></div></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 6, 2003</span>; Last Update: <span itemprop="dateModified">November 21, 2019</span>.</p><p><em>Estimated reading time: 27 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ddon.Summary" itemprop="description"><h2 id="_ddon_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Males with deafness-dystonia-optic neuronopathy (DDON) syndrome have prelingual or postlingual sensorineural hearing impairment in early childhood, slowly progressive dystonia or ataxia in the teens, slowly progressive decreased visual acuity from optic atrophy beginning at approximately age 20 years, and dementia beginning at approximately age 40 years. Psychiatric symptoms such as personality change and paranoia may appear in childhood and progress. The hearing impairment appears to be consistent in age of onset and progression, whereas the neurologic, visual, and neuropsychiatric signs vary in degree of severity and rate of progression. Females may have mild hearing impairment and focal dystonia.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of DDON syndrome is established in either a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who has a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <i>TIMM8A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (~50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males) or a female proband who has a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>TIMM8A</i> pathogenic variant (~50% of affected females) or a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> of Xp22.1 involving <i>TIMM8A</i> (~50% of affected males and females).</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Educational programs for developmental and sensory deficits, including training in tactile sign language. Because auditory neuronopathy is the cause of the hearing loss, hearing aids have only variable success. Physical medicine and rehabilitation, physical and occupational therapy to improve fine and gross motor skills and mobility, to prevent contractures, and to provide adaptive devices to improve activities of daily living. Standard treatment of behavioral issues / psychiatric disorders. Ensure appropriate social work involvement to connect families with local resources, respite, and support, especially care coordination with multiple subspecialty appointments, equipment, medications, and supplies.</p><p><i>Surveillance:</i> Regular neurologic evaluation and assessment for dementia and/or psychiatric manifestations; annual developmental, speech/language, vision assessments in childhood; regular physical therapy / occupational therapy for review of activities of daily living, gross motor and fine motor needs; routine follow up of the social support and social services needs of the family/caregivers.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>DDON syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. If the mother of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with DDON syndrome has the causative genetic alteration (i.e., a <i>TIMM8A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> of Xp22.1 involving <i>TIMM8A</i>), the chance of transmitting the genetic alteration in each pregnancy is 50%. Males who inherit the genetic alteration will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the genetic alteration will be heterozygotes and may have mild hearing impairment and focal dystonia. Males who reproduce pass the genetic alteration to all of their daughters and none of their sons.</p><p>Prenatal diagnosis for pregnancies at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if the DDON-causing genetic alteration in the family is known.</p></div></div><div id="ddon.Diagnosis"><h2 id="_ddon_Diagnosis_">Diagnosis</h2><p>Formal diagnostic criteria for deafness-dystonia-optic neuronopathy (DDON) syndrome have not been established.</p><p><b>Scope of this chapter.</b> Deafness-dystonia-optic neuronopathy (DDON) syndrome occurs as either a single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> disorder resulting from a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TIMM8A</i> or a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> at Xq22.1 that includes <i>BTK</i> and additionally causes <a href="/books/n/gene/xla/">X-linked agammaglobulinemia</a> (XLA). XLA will not be discussed further in this chapter.</p><div id="ddon.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Deafness-dystonia-optic neuronopathy (DDON) syndrome is suspected in males with the following:</p><ul><li class="half_rhythm"><div>Progressive sensorineural hearing impairment with prelingual or postlingual onset:</div><ul><li class="half_rhythm"><div>Absent stapedius reflex</div></li><li class="half_rhythm"><div>Abnormal findings on auditory brain stem response testing</div></li><li class="half_rhythm"><div>Normal evoked otoacoustic emissions, indicating normal outer hair cells [<a class="bk_pop" href="#ddon.REF.richter.2001.107">Richter et al 2001</a>]</div></li><li class="half_rhythm"><div>Normal findings on CT scan of the inner ear [<a class="bk_pop" href="#ddon.REF.mohr.1960.54">Mohr &#x00026; Mageroy 1960</a>, <a class="bk_pop" href="#ddon.REF.tranebjaerg.1995.257">Tranebjaerg et al 1995</a>]</div></li></ul></li><li class="half_rhythm"><div>Movement disorder (dystonia/ataxia)</div></li><li class="half_rhythm"><div>Gradual onset and slow progression of personality changes, paranoia, dementia</div></li><li class="half_rhythm"><div>Gradual decrease in visual acuity associated with optic atrophy</div></li><li class="half_rhythm"><div>Gradual onset and slow progression of dysphagia</div></li><li class="half_rhythm"><div>A family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance</div></li></ul></div><div id="ddon.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of deafness-dystonia-optic neuronopathy (DDON) syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who has <b>one of the following</b> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1216/table/ddon.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figddonTmoleculargenetictestingusedin" rid-ob="figobddonTmoleculargenetictestingusedin">Table 1</a>) [<a class="bk_pop" href="#ddon.REF.tranebjaerg.2012">Tranebjaerg 2012</a>]:</p><ul><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <i>TIMM8A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (~50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males) or a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>TIMM8A</i> pathogenic variant in a female proband (~50% of affected females)</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> of Xp22.1 involving <i>TIMM8A</i> (~50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males and females)</div></li></ul><p>Options for <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can include a <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis (CMA) or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and family history.</p><p>Note: The clinical features of DDON in individuals with a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> and in individuals with smaller pathogenic variants are indistinguishable, apart from the additional presence of <a href="/books/n/gene/xla/">X-linked agammaglobulinemia</a> in the former.</p><div id="ddon.Option_1"><h4>Option 1</h4><p>In a child with hearing loss and evidence of a family history suggestive of XLA, <b>CMA</b> should be performed first. CMA uses oligonucleotide or SNP arrays to detect genome-wide large deletions/duplications (including <i>TIMM8A</i>) that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p></div><div id="ddon.Option_2"><h4>Option 2</h4><p>In a young child with hearing impairment and no other phenotypic findings, there should be a strong suspicion of DDON if the auditory <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is auditory neuropathy. <b>A deafness / hearing impairment</b> or an <b>auditory neuropathy <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>TIMM8A</i> and other genes of interest (see <a href="#ddon.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying phenotype. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended; however, breakpoints of large deletions and/or deletion of adjacent genes (e.g., <i>BTK</i> as described by <a class="bk_pop" href="#ddon.REF.sediv_.2007.640">Sediv&#x000e1; et al [2007]</a>) may not be detected by these methods and would require CMA for detection (see <a class="figpopup" href="/books/NBK1216/table/ddon.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figddonTmoleculargenetictestingusedin" rid-ob="figobddonTmoleculargenetictestingusedin">Table 1</a>).</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><div id="ddon.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in DDON Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1216/table/ddon.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ddon.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ddon.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ddon.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_ddon.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_ddon.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>TIMM8A</i></td><td headers="hd_h_ddon.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_ddon.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22/42&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_ddon.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_ddon.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20/42&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_ddon.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>8</sup></td><td headers="hd_h_ddon.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18/42&#x000a0;<sup>9</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ddon.TF.1.1"><p class="no_margin">See <a href="/books/NBK1216/#ddon.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ddon.TF.1.2"><p class="no_margin">See <a href="#ddon.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="ddon.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="ddon.TF.1.4"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a></p></div></dd><dt>5. </dt><dd><div id="ddon.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#ddon.REF.tranebjaerg.2012">Tranebjaerg [2012]</a>, <a class="bk_pop" href="#ddon.REF.montaut.2018.1234">Montaut et al [2018]</a>, <a class="bk_pop" href="#ddon.REF.wang.2019.11">Wang et al [2019]</a></p></div></dd><dt>6. </dt><dd><div id="ddon.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications. Gene-targeted deletion/duplication testing will detect deletions ranging from a single exon to the whole gene; however, breakpoints of large deletions and/or deletion of adjacent genes (e.g., those described by <a class="bk_pop" href="#ddon.REF.sediv_.2007.640">Sediv&#x000e1; et al [2007]</a>) may not be detected by these methods.</p></div></dd><dt>7. </dt><dd><div id="ddon.TF.1.7"><p class="no_margin">Most deletions not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> are large deletions that include <i>BTK</i>. A single intragenic <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> has been reported [<a class="bk_pop" href="#ddon.REF.ha.2012.1034">Ha et al 2012</a>].</p></div></dd><dt>8. </dt><dd><div id="ddon.TF.1.8"><p class="no_margin">Chromosomal microarray analysis (CMA) uses oligonucleotide or SNP arrays to detect genome-wide large deletions/duplications (including <i>TIMM8A</i>) that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>. The ability to determine the size of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> depends on the type of microarray used and the density of probes in the Xq22.1 region. CMA designs in current clinical use target the Xq22.1 region.</p></div></dd><dt>9. </dt><dd><div id="ddon.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#ddon.REF.tranebjaerg.2012">Tranebjaerg [2012]</a>, <a class="bk_pop" href="#ddon.REF.szaflarska.2018.139">Szaflarska et al [2018]</a>, <a class="bk_pop" href="#ddon.REF.wang.2019.11">Wang et al [2019]</a></p></div></dd></dl></div></div></div></div></div></div><div id="ddon.Clinical_Characteristics"><h2 id="_ddon_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ddon.Clinical_Description"><h3>Clinical Description</h3><p>Deafness-dystonia-optic neuronopathy (DDON) syndrome is a progressive disorder with prelingual or postlingual sensorineural hearing impairment in early childhood. The hearing impairment is always the presenting manifestation. Typically, DDON is associated with slowly progressive dystonia or ataxia in the teens, slowly progressive decreased visual acuity from approximately age 20 years, and dementia from approximately age 40 years. Psychiatric manifestations such as personality change and paranoia may appear in childhood and progress. The deafness and pronounced visual impairment severely compromise communication in late adulthood.</p><p>Note: The term "neuronopathy" refers to the destruction of the cell bodies of neurons and is different from "neuropathy," which is defined as a functional disturbance in the peripheral nervous system.</p><p>The hearing impairment appears to be more consistent in age of onset and progression than the neurologic, visual, and neuropsychiatric features, which vary in degree of severity and rate of progression. Life span may show extreme variation, even within a family. For example, in one large family, one member had rapidly progressive dystonia ("dystonia musculorum deformans") and died at age 16 years; other <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members died in their sixties [<a class="bk_pop" href="#ddon.REF.tranebjaerg.1995.257">Tranebjaerg et al 1995</a>].</p><p><b>Audiologic features.</b> The average age of onset of sensorineural hearing impairment is approximately 18 months, although some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have apparent <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> prelingual hearing impairment [<a class="bk_pop" href="#ddon.REF.swerdlow.2001.537">Swerdlow &#x00026; Wooten 2001</a>, <a class="bk_pop" href="#ddon.REF.ujike.2001.1004">Ujike et al 2001</a>]. The hearing impairment progresses rapidly and is typically profound before age ten years. Vestibular function is normal.</p><p>The hearing impairment results from an auditory neuropathy as shown by intact otoacoustic emissions associated with absent auditory brain stem responses in some individuals and convincing histopathologic evidence in five males with molecularly proven DDON syndrome with near-total loss of cochlear neurons and severe loss of vestibular neurons [<a class="bk_pop" href="#ddon.REF.bahmad.2007.1202">Bahmad et al 2007</a>, <a class="bk_pop" href="#ddon.REF.wang.2019.11">Wang et al 2019</a>]. As expected from auditory neuropathy many individuals with DDON syndrome, at least in early stages of the disease, have intact otoacoustic emissions [<a class="bk_pop" href="#ddon.REF.richter.2001.107">Richter et al 2001</a>, <a class="bk_pop" href="#ddon.REF.brookes.2008.121">Brookes et al 2008</a>, <a class="bk_pop" href="#ddon.REF.wang.2019.11">Wang et al 2019</a>].</p><p>Of note, <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> hearing impairment without other manifestations of DDON syndrome has not been reported with <i>TIMM8A</i> pathogenic variants.</p><p><b>Neurologic features.</b> The finding of <i>gegenhalten</i> (defined as diffuse resistance to movement of a limb) may be the first neurologic manifestation. The movement disorder may appear either as dystonia or ataxia. The onset may be as early as childhood, or much later. The movement disorder is progressive and the gait gradually becomes unstable. Affected individuals have brisk tendon reflexes, ankle clonus, and extensor plantar responses. Eventually they need a cane for walking and finally become wheelchair bound. Dystonic contractures may develop [<a class="bk_pop" href="#ddon.REF.scribanu.1976.235">Scribanu &#x00026; Kennedy 1976</a>, <a class="bk_pop" href="#ddon.REF.jensen.1981.55">Jensen 1981</a>, <a class="bk_pop" href="#ddon.REF.jensen.1987.517">Jensen et al 1987</a>, <a class="bk_pop" href="#ddon.REF.tranebjaerg.1995.257">Tranebjaerg et al 1995</a>, <a class="bk_pop" href="#ddon.REF.hayes.1998.303">Hayes et al 1998</a>].</p><p>Although many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals develop dystonia by their thirties, some, ascertained through severely affected male relatives with a typical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, have no detectable neurologic dysfunction in their thirties [<a class="bk_pop" href="#ddon.REF.ujike.2001.1004">Ujike et al 2001</a>, <a class="bk_pop" href="#ddon.REF.ha.2012.1034">Ha et al 2012</a>].</p><p>Dysphagia develops late in the course and often causes aspiration pneumonia and its complications.</p><p>A mild peripheral sensory neuropathy may be present.</p><p>Spinal cord dysfunction was present in an individual with DDON syndrome with prolonged somatosensory evoked potentials and disturbed central motor conduction to lower extremities in motor evoked potentials [<a class="bk_pop" href="#ddon.REF.binder.2003.1814">Binder et al 2003</a>].</p><p>Seizures are not characteristic.</p><p><b>Neuropsychologic features.</b> Behavioral abnormalities may be present from childhood, with mild intellectual disability, personality changes, restlessness, anxiety, reduced impulse control, aggressive outbursts, and compromised ability to concentrate. Later, paranoid psychiatric features may be present with fear of poisoned food, imaginary sensory impulses from skin, and imaginary foreign bodies in the eyes leading to self-mutilating behavior. Gradually, dementia develops.</p><p><b>Ophthalmologic features.</b> Optic neuronopathy may be subclinical for many years [<a class="bk_pop" href="#ddon.REF.ujike.2001.1004">Ujike et al 2001</a>] and may be apparent only when prolongation of the P100 wave latency is detected on visual evoked potential testing [<a class="bk_pop" href="#ddon.REF.ponjavic.1996.632">Ponjavic et al 1996</a>,<a class="bk_pop" href="#ddon.REF.tranebjaerg.2001.207">Tranebjaerg et al 2001</a>].</p><p>In childhood, color vision and visual fields are normal [<a class="bk_pop" href="#ddon.REF.tranebjaerg.1995.257">Tranebjaerg et al 1995</a>, <a class="bk_pop" href="#ddon.REF.ponjavic.1996.632">Ponjavic et al 1996</a>]. Visual impairment may first be evident in the late teens as photophobia, reduced visual acuity, acquired color vision defect, and central scotomas. Ophthalmologic examination in children reveals normal-appearing optic nerves; in adults, the optic nerves become pale. The appearance of the retina is usually normal, as are night vision and the electroretinogram [<a class="bk_pop" href="#ddon.REF.ponjavic.1996.632">Ponjavic et al 1996</a>].</p><p>Slowly progressive decline in visual acuity leads to legal blindness around age 30 to 40 years [<a class="bk_pop" href="#ddon.REF.tranebjaerg.1995.257">Tranebjaerg et al 1995</a>, <a class="bk_pop" href="#ddon.REF.ponjavic.1996.632">Ponjavic et al 1996</a>, <a class="bk_pop" href="#ddon.REF.tranebjaerg.2000a.464">Tranebjaerg et al 2000a</a>, <a class="bk_pop" href="#ddon.REF.tranebjaerg.2000b.176">Tranebjaerg et al 2000b</a>, <a class="bk_pop" href="#ddon.REF.tranebjaerg.2001.207">Tranebjaerg et al 2001</a>].</p><p><b>Other characteristics</b></p><ul><li class="half_rhythm"><div>Males with DDON syndrome have normal fertility.</div></li><li class="half_rhythm"><div>Frequent occurrence of hip fractures in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males appears to be associated with poor neuromuscular coordination and increased risk for stumbling rather than an abnormality in calcium metabolism or intrinsic bone abnormalities [<a class="bk_pop" href="#ddon.REF.tranebjaerg.1995.257">Tranebjaerg et al 1995</a>].</div></li><li class="half_rhythm"><div>Cardiomyopathy does not occur.</div></li><li class="half_rhythm"><div>Decrease in respiratory capacity does not occur, except for that related to aspiration pneumonia.</div></li></ul><div id="ddon.Heterozygotes"><h4>Heterozygotes</h4><p>Older females from the original family described by <a class="bk_pop" href="#ddon.REF.tranebjaerg.1995.257">Tranebjaerg et al [1995]</a> possibly had mild involvement. Recently, females ascertained through families with classically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males have been shown to have mild hearing impairment and focal dystonia (e.g., "writer's cramp") [<a class="bk_pop" href="#ddon.REF.swerdlow.2001.537">Swerdlow &#x00026; Wooten 2001</a>, <a class="bk_pop" href="#ddon.REF.swerdlow.2004">Swerdlow et al 2004</a>]. While skewed <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> may contribute to this phenomenon [<a class="bk_pop" href="#ddon.REF.orstavik.1996.31">Orstavik et al 1996</a>, <a class="bk_pop" href="#ddon.REF.plenge.1999.759">Plenge et al 1999</a>], X-chromosome inactivation studies were not reported in the families with the most severely involved <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females [<a class="bk_pop" href="#ddon.REF.swerdlow.2001.537">Swerdlow &#x00026; Wooten 2001</a>, <a class="bk_pop" href="#ddon.REF.swerdlow.2004">Swerdlow et al 2004</a>].</p><p>Female probands have been reported [<a class="bk_pop" href="#ddon.REF.swerdlow.2001.537">Swerdlow &#x00026; Wooten 2001</a>, <a class="bk_pop" href="#ddon.REF.klempir.2010.s398">Klempir et al 2010</a>, <a class="bk_pop" href="#ddon.REF.ha.2012.1034">Ha et al 2012</a>].</p></div><div id="ddon.Other_Studies_in_Affected_Males"><h4>Other Studies in Affected Males</h4><p><b>Neuroimaging</b> (CT, MRI, or PET scan) shows general brain atrophy in the majority of males from age 40 years or, in some cases, earlier [<a class="bk_pop" href="#ddon.REF.tranebjaerg.2001.207">Tranebjaerg et al 2001</a>].</p><p>More sophisticated neuroimaging studies such as PET/MRI reveal hypometabolic areas, predominantly over the right striatum and parietal cortex, and marked atrophy of the occipital lobes [<a class="bk_pop" href="#ddon.REF.hayes.1998.303">Hayes et al 1998</a>, <a class="bk_pop" href="#ddon.REF.swerdlow.2001.537">Swerdlow &#x00026; Wooten 2001</a>, <a class="bk_pop" href="#ddon.REF.ujike.2001.1004">Ujike et al 2001</a>, <a class="bk_pop" href="#ddon.REF.binder.2003.1814">Binder et al 2003</a>].</p><p><b>Neurophysiologic investigations</b> show cochlear dysfunction.</p><p><b>Neuropathologic abnormalities</b> include general brain atrophy and gliosis, microcalcifications, and neuronal cell death in spiral ganglion cells of the cochlea, Scarpa's ganglion, the retinal ganglion cell layer, the optic nerves, and the calcarine fissures (visual cortex) [<a class="bk_pop" href="#ddon.REF.scribanu.1976.235">Scribanu &#x00026; Kennedy 1976</a>, <a class="bk_pop" href="#ddon.REF.reskenielsen.1988.590">Reske-Nielsen et al 1988</a>, <a class="bk_pop" href="#ddon.REF.hayes.1998.303">Hayes et al 1998</a>, <a class="bk_pop" href="#ddon.REF.merchant.2001.506">Merchant et al 2001</a>, <a class="bk_pop" href="#ddon.REF.tranebjaerg.2001.207">Tranebjaerg et al 2001</a>].</p><p><b>Otopathologic findings</b> clearly support that DDON syndrome is an auditory neuropathy. Temporal bones from five individuals with molecularly verified DDON syndrome showed near-total loss of cochlear neurons and severe loss of vestibular neurons [<a class="bk_pop" href="#ddon.REF.merchant.2001.506">Merchant et al 2001</a>, <a class="bk_pop" href="#ddon.REF.bahmad.2007.1202">Bahmad et al 2007</a>].</p><p>The spinal cord is atrophic with loss of fibers in the dorsal roots and posterior columns, as seen in <a href="/books/n/gene/friedreich/">Friedreich ataxia</a> [<a class="bk_pop" href="#ddon.REF.tranebjaerg.2001.207">Tranebjaerg et al 2001</a>].</p><p><b>Muscle biopsy</b> shows normal enzyme activity of energy-generating systems, no structural abnormalities, and no aggregations of mitochondria. Electron microscopy reveals mild neurogenic atrophy [<a class="bk_pop" href="#ddon.REF.tranebjaerg.1995.257">Tranebjaerg et al 1995</a>, <a class="bk_pop" href="#ddon.REF.tranebjaerg.2001.207">Tranebjaerg et al 2001</a>, <a class="bk_pop" href="#ddon.REF.binder.2003.1814">Binder et al 2003</a>]. Activities of complexes I through IV of the mitochondrial respiratory chain in muscle biopsy revealed a mild deficiency for complex IV in a male with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> p.Gln38Ter stop variant, but no abnormalities could be demonstrated in cultivated fibroblasts [<a class="bk_pop" href="#ddon.REF.blesa.2007.285">Blesa et al 2007</a>]. No pathogenic variants were identified in the mtDNA genes encoding the complex IV subunits COI, COII, and COIII or in five tRNA mtDNA genes [<a class="bk_pop" href="#ddon.REF.blesa.2007.285">Blesa et al 2007</a>].</p></div></div><div id="ddon.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>The limited number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, the extremely variable clinical course, and the family-specific nature of each <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified limits detection of <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>.</p><p>It is noteworthy that the clinical features of DDON in individuals with a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> and in individuals with smaller pathogenic variants are indistinguishable, apart from presence or absence of <a href="/books/n/gene/xla/">X-linked agammaglobulinemia</a> in those with a contiguous gene deletion [<a class="bk_pop" href="#ddon.REF.tranebjaerg.2012">Tranebjaerg 2012</a>] (see <a href="#ddon.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</a>).</p></div><div id="ddon.Nomenclature"><h3>Nomenclature</h3><p>In 1960, Mohr and Mageroy described an <a class="def" href="/books/n/gene/glossary/def-item/x-linked-recessive/">X-linked recessive</a> childhood-onset sensorineural hearing impairment, which was believed to be nonsyndromic and thus was designated DFN-1, indicating that it was the first described X-linked nonsyndromic form of hearing impairment [<a class="bk_pop" href="#ddon.REF.mohr.1960.54">Mohr &#x00026; Mageroy 1960</a>]. <a class="bk_pop" href="#ddon.REF.tranebjaerg.1995.257">Tranebjaerg et al [1995]</a> reinvestigated the family, updated the <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a>, and identified associated neurologic, visual, and behavioral findings. The syndrome was renamed Mohr-Tranebjaerg syndrome and later deafness-dystonia-optic neuronopathy (DDON) syndrome.</p><p>Opticoacoustic nerve atrophy (Jensen syndrome), reported by <a class="bk_pop" href="#ddon.REF.jensen.1981.55">Jensen [1981]</a>, <a class="bk_pop" href="#ddon.REF.jensen.1987.517">Jensen et al [1987]</a>, and <a class="bk_pop" href="#ddon.REF.reskenielsen.1988.590">Reske-Nielsen et al [1988]</a>, and deafness-dystonia syndrome, reported clinically in two families by <a class="bk_pop" href="#ddon.REF.scribanu.1976.235">Scribanu &#x00026; Kennedy [1976]</a> and <a class="bk_pop" href="#ddon.REF.hayes.1998.303">Hayes et al [1998]</a>, are the same as DDON syndrome. <i>TIMM8A</i> pathogenic variants have been identified in individuals with these two disorders [<a class="bk_pop" href="#ddon.REF.tranebjaerg.1997.a349">Tranebjaerg et al 1997</a>, <a class="bk_pop" href="#ddon.REF.tranebjaerg.2000b.176">Tranebjaerg et al 2000b</a>, <a class="bk_pop" href="#ddon.REF.tranebjaerg.2001.207">Tranebjaerg et al 2001</a>].</p></div><div id="ddon.Prevalence"><h3>Prevalence</h3><p>The prevalence of DDON syndrome is unknown. It has been identified in several populations worldwide.</p><p>A recent comprehensive review chapter identified 91 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from 37 families [<a class="bk_pop" href="#ddon.REF.tranebjaerg.2012">Tranebjaerg 2012</a>].</p><p>Dystonia of all types occurs with a prevalence between 70 and 329 per million [<a class="bk_pop" href="#ddon.REF.esde_collaborative_group.2000.787">ESDE Collaborative Group 2000</a>]. No large-scale <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of cohorts of males with dystonia has been published.</p><p>Hearing impairment has a prevalence of 1:800, approximately 1% of which is attributed to <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance.</p></div></div><div id="ddon.Genetically_Related_Allelic_Disorde"><h2 id="_ddon_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>TIMM8A</i>.</p></div><div id="ddon.Differential_Diagnosis"><h2 id="_ddon_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Specific disorders that share features with deafness-dystonia-optic neuronopathy (DDON) syndrome</b>. See <a class="figpopup" href="/books/NBK1216/table/ddon.T.other_genes_of_interest_in_the_di/?report=objectonly" target="object" rid-figpopup="figddonTothergenesofinterestinthedi" rid-ob="figobddonTothergenesofinterestinthedi">Table 2</a>.</p><p>Note: <i>De novo</i> pathogenic variants in <i>TIMM8A</i> in some families may mimic <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance and thus complicate the ability to distinguish between <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> and autosomal causes of dystonia.</p><div id="ddon.T.other_genes_of_interest_in_the_di" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Other Genes of Interest in the Differential Diagnosis of DDON Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1216/table/ddon.T.other_genes_of_interest_in_the_di/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ddon.T.other_genes_of_interest_in_the_di_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene(s)&#x000a0;<sup>1</sup></th><th id="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_2" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4" id="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/DDON syndrome</th><th headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4" id="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from DDON syndrome</th></tr></thead><tbody><tr><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MT-TL1</i>&#x000a0;<sup>2</sup></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/melas/">MELAS</a></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mat</td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>The combination of optic atrophy, hearing loss, &#x00026; neurologic signs suggests mt disorders such as MELAS.</div></li><li class="half_rhythm"><div>See also <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>.</div></li></ul></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Dystonia uncommon in MELAS</div></li><li class="half_rhythm"><div>Short stature, generalized tonic-clonic seizures, recurrent headaches/vomiting, &#x00026; anorexia common in MELAS</div></li></ul></td></tr><tr><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SERAC1</i></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/megdel/">MEGDEL syndrome</a></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dystonia &#x00026; deafness</td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Leigh-like features, impaired oxidative phosphorylation, &#x00026; 3-methylglutaconic aciduria</td></tr><tr><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SUCLA2</i></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sucla2-def/"><i>SUCLA2</i>-related mtDNA depletion syndrome, encephalomyopathic form w/methylmalonic aciduria</a>&#x000a0;<sup>3</sup></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Progressive disorder</div></li><li class="half_rhythm"><div>Dystonia &#x00026; severe hearing impairment</div></li></ul></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypotonia, abnormal muscle histopathology, &#x00026; &#x02191; methylmalonic acid concentration</div></li><li class="half_rhythm"><div>Ophthalmologic findings normal</div></li><li class="half_rhythm"><div>Several cases reported from Faroe Islands</div></li></ul></td></tr><tr><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRPS1</i></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/arts/">Arts syndrome</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Intellectual impairment, ataxia, &#x00026; hearing impairment</td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Arts syndrome findings range from <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> hearing impairment to hearing impairment assoc w/optic atrophy, hypotonia, ataxia, ID, &#x00026; signs of peripheral neuropathy, but not dystonia.</td></tr><tr><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>XK</i></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mcleod/">McLeod neuroacanthocytosis syndrome</a></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Movement disorder, cognitive impairment, &#x00026; psychiatric symptoms in males</td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurodegenerative basal ganglia disease</div></li><li class="half_rhythm"><div>Neuromuscular manifestations incl (mostly subclinical) sensorimotor axonopathy &#x00026; clinically relevant muscle weakness or atrophy</div></li><li class="half_rhythm"><div>Hematologic manifestations: RBC acanthocytosis, compensated hemolysis, &#x00026; McLeod blood group <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></div></li><li class="half_rhythm"><div>Dilated cardiomyopathy &#x00026; arrhythmias</div></li></ul></td></tr><tr><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CDH23</i><br /><i>CIB2</i><br /><i>MYO7A</i><br /><i>PCDH15</i><br /><i>USH1C</i><br /><i>USH1G</i><br /><i>USH1H</i>&#x000a0;<sup>5</sup></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/usher1/">Usher syndrome type I</a></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_1" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Visual &#x00026; hearing impairment</div></li><li class="half_rhythm"><div>In individuals w/DDON, Usher may first be suspected because hearing impairment in DDON may be <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> &#x00026; in Usher type II may be progressive.</div></li></ul></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Impaired vision results from retinal dystrophy, which first manifests as impaired dark adaptation&#x000a0;<sup>6</sup> (vs DDON, where appearance of retina is usually normal, as are night vision &#x00026; ERG).</div></li><li class="half_rhythm"><div>No neurologic abnormalities</div></li></ul></td></tr><tr><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADGRV1</i><br /><i>USH2A</i><br /><i>WHRN</i>&#x000a0;<sup>5</sup></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/usher2/">Usher syndrome type II</a></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WFS1</i></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/wfs/">Wolfram syndrome</a></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Optic atrophy, movement disorder, dementia, &#x00026; psychiatric abnormalities may occur.</div></li><li class="half_rhythm"><div>Hearing impairment in ~60% of persons by age 20 yrs</div></li><li class="half_rhythm"><div>Consider Wolfram in <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> males (i.e., single case in a family) who appear to have DDON.</div></li></ul></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Juvenile onset of diabetes mellitus</div></li><li class="half_rhythm"><div>Involvement of most organs</div></li><li class="half_rhythm"><div>No dystonia</div></li></ul></td></tr><tr><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FXN</i></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/friedreich/">Friedreich ataxia</a></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Slowly progressive ataxia w/onset age usually &#x0003c;25 yrs</div></li><li class="half_rhythm"><div>May be assoc w/sensorineural hearing impairment (10% of persons) &#x00026; often subclinical optic atrophy (25%)</div></li></ul></td><td headers="hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_1_4 hd_h_ddon.T.other_genes_of_interest_in_the_di_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Rarely presents w/hearing impairment or optic atrophy (hearing loss is always a presenting finding in DDON)</div></li><li class="half_rhythm"><div>Dystonia &#x00026; other movement disorders uncommon</div></li><li class="half_rhythm"><div>Tendon reflexes usually (not always) depressed in Friedreich ataxia</div></li><li class="half_rhythm"><div>Cardiomyopathy common</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; CNS = central nervous system; ERG = electroretinogram; ID = intellectual disability; Mat = maternal; MELAS = mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; mt = mitochondrial; RBC = red blood cell; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="ddon.TF.2.1"><p class="no_margin">Genes are in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="ddon.TF.2.2"><p class="no_margin">The m.3243A&#x0003e;G <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the mitochondrial <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>MT-TL1</i> is present in approximately 80% of individuals with MELAS. Pathogenic variants in <i>MT-TL1</i>nor other mtDNA genes, particularly <i>MT-ND5</i>, can also cause this disorder.</p></div></dd><dt>3. </dt><dd><div id="ddon.TF.2.3"><p class="no_margin">The disorder was identified in a Muslim family and ten remotely related individuals from the Faroe Islands, where a high <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency (1 in 33) is caused by a <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> [<a class="bk_pop" href="#ddon.REF.ostergaard.2007.853">Ostergaard et al 2007</a>].</p></div></dd><dt>4. </dt><dd><div id="ddon.TF.2.4"><p class="no_margin">See also other heredodegenerative <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorders characterized by intellectual impairment, movement disorder, and hearing impairment, including Farlow syndrome (OMIM <a href="https://omim.org/entry/301840?search=301840&#x00026;highlight=301840" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">301840</a>), Schimke syndrome (OMIM <a href="http://omim.org/entry/312840" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">312840</a>), Wells syndrome (OMIM <a href="http://omim.org/entry/312910" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">312910</a>), and Schmidley syndrome (OMIM <a href="http://omim.org/entry/301790" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">301790</a>).</p></div></dd><dt>5. </dt><dd><div id="ddon.TF.2.5"><p class="no_margin">See <a href="https://omim.org/phenotypicSeries/PS276900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Phenotypic Series: Usher syndrome</a> for additional genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p></div></dd><dt>6. </dt><dd><div id="ddon.TF.2.6"><p class="no_margin">Ophthalmoscopy and electroretinography can be used to determine the cause of visual impairment.</p></div></dd></dl></div></div></div><p><b>Hearing impairment.</b> Hearing impairment shows genetic heterogeneity (see <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>). The diagnosis of DDON syndrome needs to be considered in males with prelingual hearing impairment in the absence of family history of hearing loss if more common genetic causes (e.g., <a href="/books/n/gene/dfnb1/">DFNB1</a>, <a href="/books/n/gene/pendred/">Pendred syndrome</a>) have been excluded. <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> hearing impairment without additional manifestations may be linked to other DFN loci (see <a href="/books/n/gene/dfnx1/">DFNX1 Nonsyndromic Hearing Loss and Deafness</a>).</p><p>The presence of immunodeficiency and hearing impairment in a male should raise the possibility of a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> at Xq22 involving <i>TIMM8A</i> and <i>BTK</i>.</p><p><b>Dystonia.</b> Dystonias are a heterogeneous group of disorders (see <a href="/books/n/gene/dystonia-ov/">Hereditary Dystonia Overview</a>). Hearing impairment does not appear to be commonly associated with other dystonias.</p></div><div id="ddon.Management"><h2 id="_ddon_Management_">Management</h2><div id="ddon.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p><b>Affected males.</b> To establish the extent of disease and needs in a male diagnosed with deafness-dystonia-optic neuronopathy (DDON) syndrome, the evaluations summarized in <a class="figpopup" href="/books/NBK1216/table/ddon.T.recommended_evaluations_following/?report=objectonly" target="object" rid-figpopup="figddonTrecommendedevaluationsfollowing" rid-ob="figobddonTrecommendedevaluationsfollowing">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="ddon.T.recommended_evaluations_following" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Males with DDON Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1216/table/ddon.T.recommended_evaluations_following/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ddon.T.recommended_evaluations_following_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ddon.T.recommended_evaluations_following_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_ddon.T.recommended_evaluations_following_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_ddon.T.recommended_evaluations_following_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing</b><br /><b>impairment</b></td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Formal audiologic assessment w/focus on possibility of auditory neuropathy</td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To determine extent of hearing impairment</td></tr><tr><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Speech &#x00026; language assessment</td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To determine speech therapy needs</td></tr><tr><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dystonia/Ataxia</b></td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic assessment</td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To provide baseline information</td></tr><tr><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Orthopedics / physical medicine &#x00026; rehabilitation / PT / OT evaluation</td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl assessment of:
<ul><li class="half_rhythm"><div>Gross motor &#x00026; fine motor skills</div></li><li class="half_rhythm"><div>Mobility, activities of daily living, &#x00026; need for adaptive devices</div></li><li class="half_rhythm"><div>Need for PT (to improve gross motor skills) &#x00026;/or OT (to improve fine motor skills)</div></li></ul></td></tr><tr><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Vision</b><br /><b>impairment</b></td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation incl VEP</td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl visual acuity, color vision testing, visual field testing for evidence of central scotomas</td></tr><tr><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Development</b></td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment; consider specialized testing for deaf &#x00026;/or visually impaired persons.</td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl motor, adaptive, cognitive evaluation for early intervention / special education</td></tr><tr><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Psychiatric/</b><br /><b>Behavioral</b></td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuropsychiatric evaluation</td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For individuals w/dementia &#x00026;/or psychiatric disturbance</td></tr><tr><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a></td></tr><tr><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Family support/resources</td><td headers="hd_h_ddon.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess:
<ul><li class="half_rhythm"><div>Use of community or online resources (e.g., Parent to Parent)</div></li><li class="half_rhythm"><div>Need for social work involvement for parental support</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">OT = occupational therapy; PT = physical therapy; VEP = visual evoked potential</p></div></dd></dl></div></div></div><p><b>Heterozygous females.</b> The evaluation of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> female depends on whether she is a symptomatic <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (see <a class="figpopup" href="/books/NBK1216/table/ddon.T.recommended_evaluations_following/?report=objectonly" target="object" rid-figpopup="figddonTrecommendedevaluationsfollowing" rid-ob="figobddonTrecommendedevaluationsfollowing">Table 3</a>) or primarily a healthy female relative of a male proband.</p></div><div id="ddon.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="ddon.T.treatment_of_manifestations_in_in" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with DDON Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1216/table/ddon.T.treatment_of_manifestations_in_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ddon.T.treatment_of_manifestations_in_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/<br />Concern</th><th id="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Poor visual acuity / blindness</b></td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Corrective lenses / standard treatment</td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Community vision services through early intervention or school district</td></tr><tr><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing impairment / deafness</b></td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment of SNHL, w/focus on auditory neuropathy, depends on degree of hearing impairment.&#x000a0;<sup>1</sup></td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Start hearing habituation (auditory &#x00026; speech training, sign language) as soon as possible.</div></li><li class="half_rhythm"><div>Community hearing services through early intervention or school district</div></li></ul></td></tr><tr><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Cochlear implant</td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>CT of bony landmarks &#x00026; MRI of vestibular &#x00026; facial nerves as part of pre-cochlear implant assessment&#x000a0;<sup>2,&#x000a0;3</sup></div></li><li class="half_rhythm"><div>Cochlear implants may provide sound awareness &#x00026; even speech recognition in presence of cochlear abnormalities.&#x000a0;<sup>4</sup></div></li><li class="half_rhythm"><div>Outcome is expected to be variable in auditory neuropathy.</div></li></ul></td></tr><tr><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Communication</b></td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Depends on degree of hearing &#x00026; vision impairment</td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to community deaf-blind services &#x00026; state Deafblind Project as soon as possible after birth.&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dystonia</b></td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Physical medicine &#x00026; rehabilitation / PT / OT</td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>To improve gross motor skills &#x00026; mobility &#x00026; prevent contractures</div></li><li class="half_rhythm"><div>To improve fine motor skills</div></li><li class="half_rhythm"><div>Provide adaptive devices to improve activities of daily living.</div></li></ul></td></tr><tr><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>DD/ID</b></td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="#ddon.Developmental_Delay__Intellectual_D">Developmental Delay / Intellectual Disability Management Issues</a>.</td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Behavioral</b><br /><b>concerns</b></td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard medications for obsessive-compulsive disorder</td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Behavioral therapy combined w/stress reduction is sometimes helpful.</td></tr><tr><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Behavior therapy, stress reduction, &#x00026; standard medications for pervasive developmental disorder</td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Behaviors may mimic autism but are different;&#x000a0;<sup>9</sup> may be exacerbated by sensory processing issues.</td></tr><tr><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Establish an appropriate method of communication &#x00026; provide adequate stimulation for exploration in a safe environment for ADHD.</td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May be more helpful than medication</td></tr><tr><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Family needs</b></td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Ensure appropriate social work involvement to connect families w/local resources, respite, &#x00026; support.</td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ongoing assessment for need of home nursing</td></tr><tr><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">Coordinate care to manage multiple subspecialty appointments, equipment, medications, &#x00026; supplies</td><td headers="hd_h_ddon.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider involvement in adaptive sports or Special Olympics.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ADHD = attention-deficit/hyperactivity disorder; DD/ID = developmental delay / intellectual disability; OT = occupational therapy; PT = physical therapy; SNHL = sensorineural hearing loss</p></div></dd><dt>1. </dt><dd><div id="ddon.TF.4.1"><p class="no_margin">See <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a> for details about treatment options.</p></div></dd></dl></div></div></div><div id="ddon.Developmental_Delay__Intellectual_D"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy as well as infant mental health services, special educators, and sensory impairment specialists. In the US, early intervention is a federally funded program available in all states that provides in-home services to target individual therapy needs.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed for those who qualify based on established motor, language, social, or cognitive delay. The early intervention program typically assists with this transition. Developmental preschool is center based; for children too medically unstable to attend, home-based services are provided.</p><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies (US) and to support parents in maximizing quality of life. Some issues to consider:</p><ul><li class="half_rhythm"><div>Individualized education plan (IEP) services:</div><ul><li class="half_rhythm"><div>An IEP provides specially designed instruction and related services to children who qualify.</div></li><li class="half_rhythm"><div>IEP services will be reviewed annually to determine whether any changes are needed.</div></li><li class="half_rhythm"><div>As required by special education law, children should be in the least restrictive environment feasible at school and included in general education as much as possible and when appropriate.</div></li><li class="half_rhythm"><div>Vision and hearing consultants should be a part of the child's IEP team to support access to academic material.</div></li><li class="half_rhythm"><div>PT, OT, and speech services will be provided in the IEP to the extent that the need affects the child's access to academic material. Beyond that, <a class="def" href="/books/n/gene/glossary/def-item/private/">private</a> supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs may be considered. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</div></li><li class="half_rhythm"><div>As a child enters the teen years, a transition plan should be discussed and incorporated in the IEP. For those receiving IEP services, the public school district is required to provide services until age 21.</div></li></ul></li><li class="half_rhythm"><div>A 504 plan (Section 504: a US federal statute that prohibits discrimination based on disability) can be considered for those who require accommodations or modifications such as front-of-class seating, assistive technology devices, classroom scribes, extra time between classes, modified assignments, and enlarged text.</div></li><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a US public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="ddon.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility and to reduce the risk for later-onset orthopedic complications (e.g., contractures, scoliosis, hip dislocation).</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment and positioning devices as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li><li class="half_rhythm"><div>For muscle tone abnormalities including hypertonia or dystonia, consider involving appropriate specialists to aid in management of baclofen, tizanidine, Botox<sup>&#x000ae;</sup>, anti-parkinsonian medications, or orthopedic procedures.</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction</b> should be assessed at each visit and clinical feeding evaluations and/or radiographic swallowing studies should be obtained for choking/gagging during feeds, poor weight gain, frequent respiratory illnesses, or feeding refusal that is not otherwise explained. Assuming that the child is safe to eat by mouth, feeding therapy (typically by an occupational or speech therapist) is recommended to help improve coordination or sensory-related feeding issues. Feeds can be thickened or chilled for safety. When feeding dysfunction is severe, an NG-tube or G-tube may be necessary.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties. An AAC evaluation can be completed by a speech-language pathologist who has expertise in the area. The evaluation will consider cognitive abilities and sensory impairments to determine the most appropriate form of communication. AAC devices can range from low-tech, such as picture exchange communication, to high-tech, such as voice-generating devices. Contrary to popular belief, AAC devices do not hinder verbal development of speech and in many cases, can improve it.</p></div><div id="ddon.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications, such as medication used to treat attention-deficit/hyperactivity disorder, when necessary.</p><p>Concerns about serious aggressive or destructive behavior can be addressed by a pediatric psychiatrist.</p></div></div><div id="ddon.Surveillance"><h3>Surveillance</h3><div id="ddon.T.recommended_surveillance_for_indi" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with DDON Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1216/table/ddon.T.recommended_surveillance_for_indi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ddon.T.recommended_surveillance_for_indi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing impairment</b></td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Audiologic evaluation</td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Speech &#x00026; language development</b></td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">By speech &#x00026; language therapist</td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dystonia</b></td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic examination to monitor progression of dystonia &#x00026; review medications</td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Regular follow up depending on rate of progression</td></tr><tr><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">PT/OT: review activities of daily living, gross motor &#x00026; fine motor needs</td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Regular follow up depending on rate of progression</td></tr><tr><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Vision impairment</b></td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Visual acuity</td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Regular follow up depending on rate of progression</td></tr><tr><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Psychiatric/</b><br /><b>Behavioral</b></td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">When clinically relevant</td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Individual follow up based on clinical findings</td></tr><tr><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Developmental</b><br /><b>progress &#x00026;</b><br /><b>educational needs</b></td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Effect of hearing impairment, vision impairment, movement disorder, changes in behavior &#x00026;/or cognitive abilities when clinically relevant</div></li><li class="half_rhythm"><div>Be aware of signs of dementia in adults.</div></li></ul></td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Individual program for follow up</td></tr><tr><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Family/caregiver</b><br /><b>needs</b></td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess need for social work support (e.g., respite care, home nursing, other local resources) &#x00026; care coordination.</td><td headers="hd_h_ddon.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">OT = occupational therapy; PT = physical therapy</p></div></dd></dl></div></div></div></div><div id="ddon.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#ddon.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ddon.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="ddon.Genetic_Counseling"><h2 id="_ddon_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ddon.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Deafness-dystonia-optic neuronopathy (DDON) syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="ddon.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disorder nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the DDON syndrome-causing genetic alteration (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TIMM8A</i> or a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> at Xq22.1); therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>If a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a sib with the same DDON syndrome-causing genetic alteration, the mother of the proband is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a>. Note: If a woman has more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child and no other affected relatives and if the DDON syndrome-causing genetic alteration cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> (maternal germline mosaicism has been suspected but not molecularly proven in any published cases).</div></li><li class="half_rhythm"><div>If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the DDON syndrome-causing genetic alteration or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> DDON syndrome-causing genetic alteration, in which case the mother is not a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a>. <i>De novo</i> deletions have been documented in multiple cases [<a class="bk_pop" href="#ddon.REF.tranebjaerg.2000a.464">Tranebjaerg et al 2000a</a>, <a class="bk_pop" href="#ddon.REF.blesa.2007.285">Blesa et al 2007</a>, <a class="bk_pop" href="#ddon.REF.brookes.2008.121">Brookes et al 2008</a>, <a class="bk_pop" href="#ddon.REF.tranebjaerg.2012">Tranebjaerg 2012</a>].</div></li></ul><p><b>Parents of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>A female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may have inherited the DDON syndrome-causing genetic alteration from either her mother or her father, or the DDON syndrome-causing genetic alteration may be <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>.</div></li><li class="half_rhythm"><div>Detailed evaluation of the parents and review of the extended family history may help distinguish probands with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> DDON syndrome-causing genetic alteration from those with an inherited genetic alteration. Molecular genetic testing of the mother (and possibly the father, or subsequently the father) can help to determine if the genetic alteration was inherited. (Note: Parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> would not be detected by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of leukocyte DNA.)</div></li></ul><p><b>Sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a DDON syndrome-causing genetic alteration, the chance of transmitting it in each pregnancy is 50%. Males who inherit the genetic alteration will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the genetic alteration will be heterozygotes and may present with mild hearing loss or focal dystonia at an older age (see Clinical Description, <a href="#ddon.Heterozygotes">Heterozygotes</a>).</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case and if the DDON syndrome-causing genetic alteration cannot be detected in the leukocyte DNA of the mother, the risk to sibs is low but greater than that of the general population because of the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Sibs of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the parents:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the DDON syndrome-causing genetic alteration, the chance of transmitting it in each pregnancy is 50%. Males who inherit the genetic alteration will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the genetic alteration will be heterozygotes and may present with mild hearing impairment or focal dystonia at an older age (see Clinical Description, <a href="#ddon.Heterozygotes">Heterozygotes</a>).</div></li><li class="half_rhythm"><div>If the father of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a DDON syndrome-causing genetic alteration, he will transmit it to all of his daughters and none of his sons.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the DDON syndrome-causing genetic alteration cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Males who reproduce pass the DDON syndrome-causing genetic alteration to all of their daughters and none of their sons.</p><p><b>Offspring of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Women with a DDON syndrome-causing genetic alteration have a 50% chance of transmitting the genetic alteration to each child.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the genetic alteration, his or her family members may be at risk.</p></div><div id="ddon.Heterozygote_Detection"><h3>Heterozygote Detection</h3><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is possible if the DDON syndrome-causing genetic alteration in the family has been identified.</p><p><b>Specific risk issues.</b> The absence of manifestations in most young <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females may present families with additional challenges in clarifying risk status if the DDON syndrome-causing genetic alteration in the family has not been identified. It is unknown whether <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> studies could be used to detect skewed X-chromosome inactivation in heterozygotes.</p></div><div id="ddon.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>The progression of individual symptoms shows considerable inter- and <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a>, making a reliable prediction of the degree of severity difficult. Some families have shown skewed <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females, which may explain the occurrence of mild manifestations in some heterozygous females [<a class="bk_pop" href="#ddon.REF.orstavik.1996.31">Orstavik et al 1996</a>, <a class="bk_pop" href="#ddon.REF.plenge.1999.759">Plenge et al 1999</a>].</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of genetic status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ddon.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the DDON syndrome-causing genetic alteration has been identified in the family, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="ddon.Resources"><h2 id="_ddon_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Dystonia Society</b></div><div>89 Albert Embankment</div><div>3rd Floor</div><div>London SE1 7TP</div><div>United Kingdom</div><div><b>Phone:</b> 0845 458 6211; 0845 458 6322 (Helpline)</div><div><b>Fax:</b> 0845 458 6311</div><div><b>Email:</b> support@dystonia.org.uk</div><div><a href="http://www.dystonia.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dystonia.org.uk</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/deafness-dystonia-optic-neuronopathy-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Deafness-dystonia-optic neuronopathy syndrome</a></div></li><li class="half_rhythm"><div><b>American Society for Deaf Children (ASDC)</b></div><div>800 Florida Avenue Northeast</div><div>Suite 2047</div><div>Washington DC 20002-3695</div><div><b>Phone:</b> 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)</div><div><b>Fax:</b> 410-795-0965</div><div><b>Email:</b> info@deafchildren.org; asdc@deafchildren.org</div><div><a href="http://www.deafchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.deafchildren.org</a></div></li><li class="half_rhythm"><div><b>BabyHearing.org</b></div><div><i>This site, developed with support from the National Institute on Deafness and Other Communication Disorders, provides information about newborn hearing screening and hearing loss.</i></div><div><a href="http://www.babyhearing.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.babyhearing.org</a></div></li><li class="half_rhythm"><div><b>Dystonia Medical Research Foundation</b></div><div>One East Wacker Drive</div><div>Suite 1730</div><div>Chicago IL 60601-1905</div><div><b>Phone:</b> 800-377-3978 (toll-free); 312-755-0198</div><div><b>Fax:</b> 312-803-0138</div><div><b>Email:</b> dystonia@dystonia-foundation.org</div><div><a href="http://www.dystonia-foundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dystonia-foundation.org</a></div></li><li class="half_rhythm"><div><b>National Association of the Deaf (NAD)</b></div><div>8630 Fenton Street</div><div>Suite 820</div><div>Silver Spring MD 20910</div><div><b>Phone:</b> 301-587-1788; 301-587-1789 (TTY)</div><div><b>Fax:</b> 301-587-1791</div><div><b>Email:</b> nad.info@nad.org</div><div><a href="http://www.nad.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nad.org</a></div></li></ul></div><div id="ddon.Molecular_Genetics"><h2 id="_ddon_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ddon.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Deafness-Dystonia-Optic Neuronopathy Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1216/table/ddon.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ddon.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ddon.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ddon.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ddon.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ddon.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ddon.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ddon.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1678" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TIMM8A</i></a></td><td headers="hd_b_ddon.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1678" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq22<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_ddon.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O60220" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mitochondrial import inner membrane translocase subunit Tim8 A</a></td><td headers="hd_b_ddon.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TIMM8A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TIMM8A</a></td><td headers="hd_b_ddon.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TIMM8A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TIMM8A</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ddon.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ddon.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Deafness-Dystonia-Optic Neuronopathy Syndrome (<a href="/omim/300356,304700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1216/table/ddon.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ddon.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300356" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300356</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 8, YEAST, HOMOLOG OF, A; TIMM8A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/304700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">304700</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MOHR-TRANEBJAERG SYNDROME; MTS</td></tr></tbody></table></div></div><div id="ddon.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><i>TIMM8A</i> encodes the 97-amino acid mitochondrial import inner membrane translocase subunit TIMM8A involved in the mitochondrial transport processes. The yeast ortholog, Tim8p, is similar to five small yeast mitochondrial intermembrane space proteins &#x02013; Tim8p, Tim9p, Tim10p, Tim12p, and Tim13p &#x02013; but is most similar to Tim8p, which exists as a soluble 70-kd complex with Tim13p and Tim9p [<a class="bk_pop" href="#ddon.REF.koehler.1999a.2141">Koehler et al 1999a</a>, <a class="bk_pop" href="#ddon.REF.koehler.1999b.428">Koehler et al 1999b</a>].</p><p>TIMM8A contains putative Zn-binding domains with four conserved cysteine residues. The product is involved in mitochondrial protein import [<a class="bk_pop" href="#ddon.REF.koehler.1999a.2141">Koehler et al 1999a</a>, <a class="bk_pop" href="#ddon.REF.koehler.1999b.428">Koehler et al 1999b</a>], and like the yeast Tim8p, it assembles in a 70-kd complex in the mitochondrial intermembrane space with mitochondrial import inner membrane translocase subunit TIMM13, the protein encoded by <i>TIMM13</i>. Evidence from yeast indicates that this complex is critical for the import of TIMM23, which therefore may be insufficiently present in the inner membrane, resulting in the human disorder [<a class="bk_pop" href="#ddon.REF.roesch.2002.477">Roesch et al 2002</a>].</p><p>Protein expression and immunocytochemical studies indicate that TIMM8A and TIMM13 are coexpressed at high levels in Purkinje cells in the cerebellum, but not in glial cells [<a class="bk_pop" href="#ddon.REF.roesch.2004.2101">Roesch et al 2004</a>]. Expression and import studies show that the calcium-binding aspartate/glutamate carriers, citrin and aralar1, are new substrates for the TIMM8A/TIMM13 protein complex [<a class="bk_pop" href="#ddon.REF.roesch.2004.2101">Roesch et al 2004</a>]. The morphology of muscle mitochondria and biochemical characterization are only borderline abnormal [<a class="bk_pop" href="#ddon.REF.koehler.1999a.2141">Koehler et al 1999a</a>, <a class="bk_pop" href="#ddon.REF.koehler.1999b.428">Koehler et al 1999b</a>, <a class="bk_pop" href="#ddon.REF.paschen.2000.6392">Paschen et al 2000</a>, <a class="bk_pop" href="#ddon.REF.tranebjaerg.2000a.464">Tranebjaerg et al 2000a</a>, <a class="bk_pop" href="#ddon.REF.rothbauer.2001.37327">Rothbauer et al 2001</a>, <a class="bk_pop" href="#ddon.REF.tranebjaerg.2001.207">Tranebjaerg et al 2001</a>].</p><p><b>Mechanism of disease causation.</b> DDON occurs through a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> mechanism.</p><p>Deletion of <i>TIMM8A</i> as part of a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> that includes <i>BTK</i> occurs frequently, resulting in the presence of both DDON and <a href="/books/n/gene/xla/">X-linked agammaglobulinemia</a> (XLA) [<a class="bk_pop" href="#ddon.REF.tranebjaerg.2012">Tranebjaerg 2012</a>]. Of note, deletion breakpoints preferentially involve Alu elements in smaller deletions (&#x0003c;10 kb) in individuals with both DDON and XLA [<a class="bk_pop" href="#ddon.REF.arai.2011.577">Arai et al 2011</a>, <a class="bk_pop" href="#ddon.REF.tranebjaerg.2012">Tranebjaerg 2012</a>].</p><p>Although some variants are inherited, <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> variants are often observed [<a class="bk_pop" href="#ddon.REF.tranebjaerg.2012">Tranebjaerg 2012</a>].</p><p><b><i>TIMM8A</i>-specific laboratory technical considerations</b></p><ul><li class="half_rhythm"><div><i>TIMM8A</i> comprises only two exons.</div></li><li class="half_rhythm"><div><i>TIMM8A</i> has a <a class="def" href="/books/n/gene/glossary/def-item/pseudogene/">pseudogene</a>, <i>TIMM8AP1.</i> Since <i>TIMM8AP1</i> is a processed pseudogene, and since there are a sufficient number of sequence differences between the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and pseudogene, it appears unlikely that <i>TIMM8AP1</i> will interfere with the analysis of <i>TIMM8A.</i></div></li></ul></div></div><div id="ddon.References"><h2 id="_ddon_References_">References</h2><div id="ddon.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.arai.2011.577">Arai T, Zhao M, Kanegane H, van Zelm MC, Futatani T, Yamada M, Ariga T, Ochs HD, Miyawaki T, Oh-ishi T. Genetic analysis of contiguous nX-chromosome deletion syndrome encompassing the BTK and TIMM8A genes. <span><span class="ref-journal">J Hum Genet. </span>2011;<span class="ref-vol">56</span>:577–82.</span> [<a href="/pubmed/21753765" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21753765</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.bahmad.2007.1202">Bahmad F Jr, Merchant SN, Nadol JB Jr, Tranebjaerg L. Otopathology in Mohr-Tranebjaerg syndrome. <span><span class="ref-journal">Laryngoscope. </span>2007;<span class="ref-vol">117</span>:1202–8.</span> [<a href="/pmc/articles/PMC2515094/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2515094</span></a>] [<a href="/pubmed/17471106" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17471106</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.binder.2003.1814">Binder J, Hofmann S, Kreisel S, Wohrle JC, Bazner H, Krauss JK, Hennerici MG, Bauer MF. Clinical and molecular findings in a patient with a novel mutation in the deafness-dystonia peptide (DDP1) gene. <span><span class="ref-journal">Brain. </span>2003;<span class="ref-vol">126</span>:1814–20.</span> [<a href="/pubmed/12805099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12805099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.blesa.2007.285">Blesa JR, Solano A, Briones P, Prieto-Ruiz JA, Hernandez-Yago J, Coria F. Molecular genetics of a patient with Mohr-Tranebjaerg Syndrome due to a new mutation in the DDP1 gene. <span><span class="ref-journal">Neuromolecular Med. </span>2007;<span class="ref-vol">9</span>:285–91.</span> [<a href="/pubmed/17999202" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17999202</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.brookes.2008.121">Brookes JT, Kanis AB, Tan LY, Tranebjaerg L, Vore A, Smith RJ. Cochlear implantation in deafness-dystonia-optic neuronopathy (DDON) syndrome. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>2008;<span class="ref-vol">72</span>:121–6.</span> [<a href="/pubmed/17936919" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17936919</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.esde_collaborative_group.2000.787">ESDE Collaborative Group.  A prevalence study of primary dystonia in eight European countries. <span><span class="ref-journal">J Neurol. </span>2000;<span class="ref-vol">247</span>:787–92.</span> [<a href="/pubmed/11127535" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11127535</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.ha.2012.1034">Ha AD, Parratt KL, Rendtorff ND, Lodahl M, Ng K, Rowe DB, Sue CM, Morris JG, Hayes MW, Tranebjaerg L, Fung VSC. The phenotypic spectrum of dystonia in Mohr-Tranebjaerg syndrome. <span><span class="ref-journal">Mov Disord. </span>2012;<span class="ref-vol">27</span>:1034–40.</span> [<a href="/pubmed/22736418" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22736418</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.hayes.1998.303">Hayes MW, Ouvrier RA, Evans W, Somerville E, Morris JG. X-linked dystonia-deafness syndrome. <span><span class="ref-journal">Mov Disord. </span>1998;<span class="ref-vol">13</span>:303–8.</span> [<a href="/pubmed/9539345" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9539345</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.jensen.1981.55">Jensen PK. Nerve deafness: optic nerve atrophy, and dementia: a new X-linked recessive syndrome? <span><span class="ref-journal">Am J Med Genet. </span>1981;<span class="ref-vol">9</span>:55–60.</span> [<a href="/pubmed/7195649" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7195649</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.jensen.1987.517">Jensen PK, Reske-Nielsen E, Hein-Sorensen O, Warburg M. The syndrome of opticoacoustic nerve atrophy with dementia. <span><span class="ref-journal">Am J Med Genet. </span>1987;<span class="ref-vol">28</span>:517–8.</span> [<a href="/pubmed/3425626" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3425626</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.klempir.2010.s398">Klempir J, Klempirova O, Hadac J, Roth J. Late-onset severe progressive Mohr-Tranebjaerg syndrome in two female relatives. <span><span class="ref-journal">Eur J Neurol. </span>2010;<span class="ref-vol">17</span> Suppl 3:S398.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.koehler.1999a.2141">Koehler CM, Leuenberger D, Merchant S, Renold A, Junne T, Schatz G. Human deafness dystonia syndrome is a mitochondrial disease. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>1999a;<span class="ref-vol">96</span>:2141–6.</span> [<a href="/pmc/articles/PMC26750/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC26750</span></a>] [<a href="/pubmed/10051608" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10051608</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.koehler.1999b.428">Koehler CM, Merchant S, Schatz G. How membrane proteins travel across the mitochondrial intermembrane space. <span><span class="ref-journal">Trends Biochem Sci. </span>1999b;<span class="ref-vol">24</span>:428–32.</span> [<a href="/pubmed/10542408" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10542408</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.merchant.2001.506">Merchant SN, McKenna MJ, Nadol JB Jr, Kristiansen AG, Tropitzsch A, Lindal S, Tranebjaerg L. Temporal bone histopathologic and genetic studies in Mohr-Tranebjaerg syndrome (DFN-1). <span><span class="ref-journal">Otol Neurotol. </span>2001;<span class="ref-vol">22</span>:506–11.</span> [<a href="/pubmed/11449109" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11449109</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.mohr.1960.54">Mohr J, Mageroy K. Sex-linked deafness of a possibly new type. <span><span class="ref-journal">Acta Genet Stat Med. </span>1960;<span class="ref-vol">10</span>:54–62.</span> [<a href="/pubmed/13771732" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13771732</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.montaut.2018.1234">Montaut S, Tranchant C, Drouot N, Rudolf G, Guissart C, Tarabeux J, Stemmelen T, Velt A, Fourrage C, Nitschk&#x000e9; P, Gerard B, Mandel JL, Koenig M, Chelly J, Anheim M, et al.  Assessment of a targeted gene panel for identification of genes associated with movement disorders. <span><span class="ref-journal">JAMA Neurol. </span>2018;<span class="ref-vol">75</span>:1234–45.</span> [<a href="/pmc/articles/PMC6233854/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6233854</span></a>] [<a href="/pubmed/29913018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29913018</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.orstavik.1996.31">Orstavik KH, Orstavik RE, Eiklid K, Tranebjaerg L. Inheritance of skewed X chromosome inactivation in a large family with X-linked recessive deafness syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">64</span>:31–4.</span> [<a href="/pubmed/8826445" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8826445</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.ostergaard.2007.853">Ostergaard E, Hansen FJ, Sorensen N, Duno M, Vissing J, Larsen PL, Faeroe O, Thorgrimsson S, Wibrand F, Christensen E, Schwartz M. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:853–61.</span> [<a href="/pubmed/17287286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17287286</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.paschen.2000.6392">Paschen SA, Rothbauer U, Kaldi K, Bauer MF, Neupert W, Brunner M. The role of the TIM8-13 complex in the import of Tim23 into mitochondria. <span><span class="ref-journal">EMBO J. </span>2000;<span class="ref-vol">19</span>:6392–400.</span> [<a href="/pmc/articles/PMC305865/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC305865</span></a>] [<a href="/pubmed/11101512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11101512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.plenge.1999.759">Plenge RM, Tranebjaerg L, Jensen PK, Schwartz C, Willard HF. Evidence that mutations in the X-linked DDP gene cause incompletely penetrant and variable skewed X inactivation. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:759–67.</span> [<a href="/pmc/articles/PMC1377793/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377793</span></a>] [<a href="/pubmed/10053010" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10053010</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.ponjavic.1996.632">Ponjavic V, Andreasson S, Tranebjaerg L, Lubs HA. Full-field electroretinograms in a family with Mohr-Tranebjaerg syndrome. <span><span class="ref-journal">Acta Ophthalmol Scand. </span>1996;<span class="ref-vol">74</span>:632–5.</span> [<a href="/pubmed/9017058" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9017058</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.reskenielsen.1988.590">Reske-Nielsen E, Jensen PK, Hein-S&#x000f8;rensen O, Abelskov K. Calcification of the central nervous system in a new hereditary neurological syndrome. <span><span class="ref-journal">Acta Neuropathol. </span>1988;<span class="ref-vol">75</span>:590–6.</span> [<a href="/pubmed/3376762" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3376762</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.richter.2001.107">Richter D, Conley ME, Rohrer J, Myers LA, Zahradka K, Kelecic J, Sertic J, Stavljenic-Rukavina A. A contiguous deletion syndrome of X-linked agammaglobulinemia and sensorineural deafness. <span><span class="ref-journal">Pediatr Allergy Immunol. </span>2001;<span class="ref-vol">12</span>:107–11.</span> [<a href="/pubmed/11338284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11338284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.roesch.2002.477">Roesch K, Curran SP, Tranebjaerg L, Koehler CM. Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex. <span><span class="ref-journal">Hum Mol Genet. </span>2002;<span class="ref-vol">11</span>:477–86.</span> [<a href="/pubmed/11875042" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11875042</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.roesch.2004.2101">Roesch K, Hynds PJ, Varga R, Tranebjaerg L, Koehler CM. The calcium-binding aspartate/glutamate carriers, citrin and aralar1, are new substrates for the DDP1/TIMM8a-TIMM13 complex. <span><span class="ref-journal">Hum Mol Genet. </span>2004;<span class="ref-vol">13</span>:2101–11.</span> [<a href="/pubmed/15254020" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15254020</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.rothbauer.2001.37327">Rothbauer U, Hofmann S, Muhlenbein N, Paschen SA, Gerbitz KD, Neupert W, Brunner M, Bauer MF. Role of the deafness dystonia peptide 1 (DDP1) in import of human Tim23 into the inner membrane of mitochondria. <span><span class="ref-journal">J Biol Chem. </span>2001;<span class="ref-vol">276</span>:37327–34.</span> [<a href="/pubmed/11489896" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11489896</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.scribanu.1976.235">Scribanu N, Kennedy C. Familial syndrome with dystonia, neural deafness, and possible intellectual impairment: clinical course and pathological findings. <span><span class="ref-journal">Adv Neurol. </span>1976;<span class="ref-vol">14</span>:235–43.</span> [<a href="/pubmed/181965" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 181965</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.sediv_.2007.640">Sediv&#x000e1; A, Smith CI, Asplund AC, Hadac J, Janda A, Zeman J, Hans&#x000ed;kov&#x000e1; H, Dvor&#x000e1;kov&#x000e1; L, Mr&#x000e1;zov&#x000e1; L, Velbri S, Koehler C, Roesch K, Sullivan KE, Futatani T, Ochs HD. Contiguous X-chromosome deletion syndrome encompassing the BTK, TIMM8A, TAF7L, and DRP2 genes. <span><span class="ref-journal">J Clin Immunol. </span>2007;<span class="ref-vol">27</span>:640–6.</span> [<a href="/pubmed/17851739" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17851739</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.swerdlow.2004">Swerdlow RH, Juel VC, Wooten GF. Dystonia with and without deafness is caused by TIMM8A mutation. In: Fahn S, Hallett M, DeLong MR, eds. <em>Dystonia 4: Advances in Neurology</em>. Vol 94. Philadelphia, PA: Lippincott Williams &#x00026; Wilkins; 2004. [<a href="/pubmed/14509668" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14509668</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.swerdlow.2001.537">Swerdlow RH, Wooten GF. A novel deafness/dystonia peptide gene mutation that causes dystonia in female carriers of Mohr-Tranebjaerg syndrome. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">50</span>:537–40.</span> [<a href="/pubmed/11601506" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11601506</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.szaflarska.2018.139">Szaflarska A, Rutkowska-Zapa&#x00142;a M, Gruca A, Szewczyk K, Bik-Multanowski M, Lenart M, Surman M, Kopyta I, G&#x00142;uszkiewicz E, Machnikowska-Soko&#x00142;owska M, Gruszczy&#x00144;ska K, Pituch-Noworolska A, Siedlar M. Neurodegenerative changes detected by neuroimaging in a patient with contiguous X-chromosome deletion syndrome encompassing BTK and TIMM8A genes. <span><span class="ref-journal">Cent Eur J Immunol. </span>2018;<span class="ref-vol">43</span>:139–47.</span> [<a href="/pmc/articles/PMC6102625/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6102625</span></a>] [<a href="/pubmed/30135625" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30135625</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.tranebjaerg.2012">Tranebjaerg L. Mitochondrial diseases caused by mutations in inner membrane chaperone proteins. In: Wong LJC, ed. <em>Mitochondrial Disorders Caused by Nuclear Genes</em>. New York, NY: Springer; 2012:337-66.</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.tranebjaerg.2000a.464">Tranebjaerg L, Hamel BC, Gabreels FJ, Renier WO, Van Ghelue M. A de novo missense mutation in a critical domain of the X-linked DDP gene causes the typical deafness-dystonia-optic atrophy syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2000a;<span class="ref-vol">8</span>:464–7.</span> [<a href="/pubmed/10878669" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10878669</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.tranebjaerg.2000b.176">Tranebjaerg L, Jensen PK, van Ghelue M. X-linked recessive deafness-dystonia syndrome (Mohr-Tranebjaerg syndrome). <span><span class="ref-journal">Adv Otorhinolaryngol. </span>2000b;<span class="ref-vol">56</span>:176–80.</span> [<a href="/pubmed/10868232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10868232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.tranebjaerg.2001.207">Tranebjaerg L, Jensen PK, Van Ghelue M, Vnencak-Jones CL, Sund S, Elgjo K, Jakobsen J, Lindal S, Warburg M, Fuglsang-Frederiksen A, Skullerud K. Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8a gene. <span><span class="ref-journal">Ophthalmic Genet. </span>2001;<span class="ref-vol">22</span>:207–23.</span> [<a href="/pubmed/11803487" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11803487</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.tranebjaerg.1995.257">Tranebjaerg L, Schwartz C, Eriksen H, Andreasson S, Ponjavic V, Dahl A, Stevenson RE, May M, Arena F, Barker D. A new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22. <span><span class="ref-journal">J Med Genet. </span>1995;<span class="ref-vol">32</span>:257–63.</span> [<a href="/pmc/articles/PMC1050371/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1050371</span></a>] [<a href="/pubmed/7643352" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7643352</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.tranebjaerg.1997.a349">Tranebjaerg L, Van Ghelue M, Nilssen O, Hodes ME, Dlouhy SR, Farlow MR, Hamel B, Arts WFM, Jankovic J, Beach J, Jensen PKA. Jensen syndrome is allelic to Mohr-Tranebjaerg syndrome and both are caused by mutations in the DDP gene. <span><span class="ref-journal">Am J Hum Genet. </span>1997;<span class="ref-vol">61S</span>:A349.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.ujike.2001.1004">Ujike H, Tanabe Y, Takehisa Y, Hayabara T, Kuroda S. A family with X-linked dystonia-deafness syndrome with a novel mutation of the DDP gene. <span><span class="ref-journal">Arch Neurol. </span>2001;<span class="ref-vol">58</span>:1004–7.</span> [<a href="/pubmed/11405816" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11405816</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ddon.REF.wang.2019.11">Wang H, Wang L, Yang J, Yin L, Lan L, Li J, Zhang Q, Wang D, Guan J, Wang Q. Phenotype prediction of Mohr-Tranebjaerg syndrome (MTS) by genetic analysis and initial auditory neuropathy. <span><span class="ref-journal">BMC Med Genet. </span>2019;<span class="ref-vol">20</span>:11.</span> [<a href="/pmc/articles/PMC6330410/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6330410</span></a>] [<a href="/pubmed/30634948" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30634948</span></a>]</div></li></ul></div></div><div id="ddon.Chapter_Notes"><h2 id="_ddon_Chapter_Notes_">Chapter Notes</h2><div id="ddon.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>21 November 2019 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>31 January 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 March 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available clinically</div></li><li class="half_rhythm"><div>3 April 2008 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 April 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 February 2004 (cd) Revision: change in testing</div></li><li class="half_rhythm"><div>6 February 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>23 August 2002 (lt) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1216</span><span class="label">PMID: <a href="/pubmed/20301395" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301395</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/dfn-myop/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/dent/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1216&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1216/?report=reader">PubReader</a></li><li><a href="/books/NBK1216/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1216" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1216" style="display:none" title="Cite this Page"><div class="bk_tt">Tranebjærg L. Deafness-Dystonia-Optic Neuronopathy Syndrome. 2003 Feb 6 [Updated 2019 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1216/pdf/Bookshelf_NBK1216.pdf">PDF version of this page</a> (507K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ddon.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ddon.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ddon.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ddon.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ddon.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ddon.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ddon.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ddon.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ddon.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ddon.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ddon.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1678[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TIMM8A</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1216+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1467340" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1467340" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1467340" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1467340" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17936919" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Cochlear implantation in deafness-dystonia-optic neuronopathy (DDON) syndrome.</a><span class="source">[Int J Pediatr Otorhinolaryngol...]</span><div class="brieflinkpop offscreen_noflow">Cochlear implantation in deafness-dystonia-optic neuronopathy (DDON) syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brookes JT, Kanis AB, Tan LY, Tranebjaerg L, Vore A, Smith RJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Int J Pediatr Otorhinolaryngol. 2008 Jan; 72(1):121-6. Epub 2007 Oct 15.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301567" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Robertson S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301451" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type II</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type II<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Scarpa M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/11803487" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8a gene.</a><span class="source">[Ophthalmic Genet. 2001]</span><div class="brieflinkpop offscreen_noflow">Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8a gene.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tranebjaerg L, Jensen PK, Van Ghelue M, Vnencak-Jones CL, Sund S, Elgjo K, Jakobsen J, Lindal S, Warburg M, Fuglsang-Frederiksen A, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ophthalmic Genet. 2001 Dec; 22(4):207-23. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301395" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301395" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0418f975f66d18aa8dce77">Deafness-Dystonia-Optic Neuronopathy Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Deafness-Dystonia-Optic Neuronopathy Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:20:41-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88F351E040D7810000000005190206&amp;ncbi_session=CE88F351E0418F81_1305SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1216%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1216&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1216/&amp;ncbi_pagename=Deafness-Dystonia-Optic Neuronopathy Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88F351E0418F81_1305SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>